Genetic control of hepatic apoB-100 secretion in human apoB transgenic mouse strains

Journal of Lipid Research

Volumn 40, Issue 11, 1999, Pages 2004-2012

  Voyiaziakis, Emanuel ^a   Ko, Carol ^a   O'Rourke, Shawn M ^a   Huang, Li Shin ^a  

^a Department of Medicine Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Congenic mouse strain; Familial combined hyperlipidemia; Genetic mapping; Inbred mouse strains; Triglyceride secretion

Indexed keywords

APOLIPOPROTEIN B100; MESSENGER RNA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC VARIABILITY; HIGH RISK POPULATION; INBRED STRAIN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; MALE; NONHUMAN; POPULATION GENETICS; PRIORITY JOURNAL; PROGENY; TRANSGENIC MOUSE;

EID: 0032743739     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Heiss, G., I. Tamir, C. E. Davis, H. A. Tyroler, B. M. Rifkand, G. Schonfeld, D. Jacobs, and I. D. Frantz, Jr. 1980. Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation. 61: 302-315.
2. Kladetzky, R. G., G. Assmann, S. Walgenhach, P. Tauchert, and H. D. Helb. 1998. Lipoprotein and apoprotein values in coronary angiography patients. Artery. 7: 191-205.
3. Sniderman, A. D., S. Shapiro, D. Marpole, B. Skinner, B. Teng, and P. O. Kwiterovich, Jr. 1980. Association of coronary atherosclerosis with hyperapobetalipoproteinemia: increased protein but normal cholesterol levels in human plasma low density β-lipoproteins. Proc. Natl. Acad. Sci. USA. 77: 604-608.
4. Kane, J. P., and R. J. Havel. 1989. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In The Metabolic Basis of Inherited Disease. C. R. Scriver, A. R. Beaudet, W. S. Sly, D. Valle, J. B. Stanbury, J. B. Wyngaarden, and D. S. Frederickson, editors. McGraw-Hill, New York. 1139-1164.
5. Chen, S. H., G. Habib, C. Yang, Z. Gu, R. Lee, S. Weng, S. R. Silberman, S. J. Cai, J. P. Deslypere, M. Rosseneu, A. M. Gotto, W. Li, and L. Chan. 1987. ApoB-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science. 238: 363-366.
6. Powell, L. M., S. C. Wallis, R. J. Pease, Y. H. Edwards, T. J. Knott, and J. Scott. 1987. A novel form of tissue-specific RNA processing produces apoB-48 in intestine. Cell. 50: 831-840.
7. Davidson, N., L. Powell, S. Wallis, and J. Scott. 1988. Thyroid hormone modulates the introduction of a stop codon in rat liver apoB mRNA. J. Biol. Chem. 263: 13482-13485.
8. Tennyson, G. E., C. A. Sabatos, T. L. Eggerman, and H. B. Brewer, Jr. 1989. Characterization of single base substitutions in edited apolipoprotein B transcripts. Nucleic Acids Res. 17: 691-698.
9. Goldstein, J. L., and M. S. Brown. 1989. Familial hypercholesterolemia. In The Metabolic Basis of Inherited Disease. C. R. Scriver, A. R. Beaudet, W. S. Sly, D. Valle, J. B. Stanbury, J. B. Wyngaarden, and D.S. Frederickson, editors. McGraw-Hill, New York. 1215-1250.
10. Soria, L. F., E. H. Ludwig, H. R. G. Clarke, G. L. Vegas, S. M. Grundy, and B. J. McCarthy. 1989. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Prof. Natl. Acad. Sci. USA. 86: 587-591.
11. Linton, M. F., R. V. Farese, Jr., and S. G. Young. 1993. Familial hypobetalipoproteinemia. J. Lipid Res. 34: 521-541.
12. Shoulders, C. C., D. J. Brett, J. D. Bayliss, M. E. Narcisi, A. Jarmuz, T. T. Grantham, R. D. Leoni, S. Bhattacharya, R. Pease, P. M. Cullen, S. Levi, P. G. H. Byfield, P. Purkiss, and J. Scott. 1993. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum. Mol. Genet. 2: 2109-2116.
13. Sharp, D., L. Blinderman, K. A. Combs, B. Kienzle, B. Ricci, K. Wager-Smith, C. M. Gil, C. W. Turck, M. Bouma, D. J. Rader, L. P. Aggerbeck, R. E. Gregg, D. A. Gordon, and J. R. Wetterau. 1993. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinemia. Nature. 365: 65-69.
14. Hasstedt, S. J., L. Wu, and R. R. Williams. 1987. Major locus inheritance of apolipoprotein B in Utah pedigrees. Genet. Epidemiol. 4: 67-76.
15. Amos, C. I., R. C. Elston, S. R. Srinivasan, A. F. Wilson, J. L. Cresanta, L. J. Ward, and G. S. Berenson. 1987. Linkage and segregation analyses of apolipoproteins AI and B, and lipoprotein cholesterol levels in a large pedigree with excess coronary heart disease. Genet. Epidemiol. 4: 115-128.
16. Pairitz, G., J. Davignon, H. Mailloux, and C. F. Sing. 1988. Sources of interindividual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic. Am. J. Hum. Genet. 43: 311-321.
17. Coresh, J., T. H. Beaty, and P. O. Kwiterovich, Jr. 1993. Inheritance of plasma apolipoprotein B levels in families of patients undergoing coronary arteriography at an early age. Genet. Epidemiol. 10: 159-176.
18. Tiret, L., J. Steinmetz, B. Herbeth, S. Visvikis, R. Rakotovao, P. Ducimetiere, and F. Cambien. 1990. Familial resemblance of plasma apolipoprotein B: The Nancy Study. Genet. Epidemiol. 7: 187-197.
19. Wang, J., D. J. Freeman, S. M. Grundy, D. M. Levine, R. Guerra, and J. C. Cohen. 1998. Linkage between cholesterol 7α-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J. Clin. Invest. 101: 1283-1291.
20. Beaty, T.H., P. O. Kwiterovich, Jr., M. J. Khoury, S. White, P. S. Bachorik, H. H. Smith, and A. Sniderman. 1986. Genetic analysis of plasma sitosterol, apoprotein B and lipoproteins in a large Amish pedigree with sitosterolemia. Am. J. Hum. Genet. 38: 492-504.
21. Karpe, R., B. Lundahl, E. Ehrenborg, P. Eriksson, and A. Hamsten. 1998. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler. Thromob. Vasc. Biol. 18: 756-761.
22. Boerwinkle, E., and C. F. Sing. 1987. The use of measured genotype information in the analysis of quantitative phenotypes in man. III. Simultaneous estimation of the frequencies and effects of the apolipoprotein E polymorphism and residual polygenetic effects on cholesterol, betalipoprotein and triglyceride levels. Am. J. Hum. Genet. 51: 211-226.
23. Breslow, J. L. 1989. Genetic basis of lipoprotein disorders. J. Clin. Invest. 84: 373-380.
24. Callow, M. J., L. J. Stoltzfus, R. M. Lawn, and E. M. Rubin. 1994. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc. Natl. Acad. Sci. USA. 91: 2130-2134.
25. Linton, M. F., R. V. Farese, Jr., G. Chiesa, D. S. Grass, P. Chin, R. E. Hammer, H. H. Hobbs, and S. G. Young. 1993. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein (a). J. Clin. Invest. 92: 3029-3937.
26. LeBoeuf, R. C., D. L. Puppione, V. N. Schumaker, and A. J. Lusis. 1983. Genetic control of lipid transport in mice. I. Structural properties and polymorphisms of plasma lipoproteins. J. Biol. Chem. 258: 5063-5070.
27. Lusis, A. J., B. A. Taylor, D. Quon, S. Zollman, and R. C. LeBoeuf. 1987. Genetic factors controlling structure and expression of apolipoproteins B and E in mice. J. Biol. Chem. 262: 7594-7604.
28. Dixon, J. L., and H. N. Ginsberg. 1993. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J. Lipid Res. 34: 167-179.
29. Yao, Z., K. Tran, and R. S. McLeod. 1997. Intracellular degradation of newly synthesized apolipoprotein B. J. Lipid Res. 38: 1937-1953.
30. Simpson, E. M., C. C. Linder, E. E. Sargent, M. T. Davisson, L. E. Mobraaten, and J. J. Sharp. 1997. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nature Genet. 16: 19-27.
31. Aalto-Setälä, K., E. A. Fisher, X. Chen, T. Chajek-Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. N. Ginsberg, and J. L. Breslow. 1992. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. J. Clin. Invest. 90: 1889-1900.
32. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
33. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
34. Heinemann, T., S. Metzger, E. A. Fisher, J. L. Breslow, and L. S. Huang. 1994. Alternative polyadenylation of apolipoprotein B RNA is a major cause of apolipoprotein B-48 formation in rat hepatoma cell lines transfected with human apoB-100 minigenes. J. Lipid Res. 35: 2200-2211.
35. Higuchi, K., K. Kitagawa, K. Kogishi, and T. Takeda. 1992. Developmental and age-related changes in apolipoprotein B mRNA editing in mice. J. Lipid Res. 33: 1753-1764.
36. Chiesa, G., D. F. Johnson, Z. Yao, T. L. Innerarity, R. W. Mahley, S. G. Young, R. H. Hammer, and H. H. Hobbs. 1993. Expression of human apolipoprotein B100 in transgenic mice. J. Biol. Chem. 268: 23747-23750.
37. LeBoeuf, R. C., M. Caldwell, and E. Kirk. 1994. Regulation by nutritional status of lipids and apolipoproteins A-I, A-II, and A-IV in inbred mice. J. Lipid Res. 35: 121-133.
38. Liang, J. S., X. Wu, H. Jiang, M. Zhou, H. Yang, P. Angkeow, L. S. Huang, S. L. Sturley, and H. Ginsberg. 1998. Translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of β sheet domains. J. Biol. Chem. 273: 35216-35221.
39. Chait, A., J. J. Albers, and J. D. Brunzell. 1980. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia. Eur. J. Clin. Invest. 10: 17-22.
40. Janus, E. D., A. M. Nicoll, P. R. Turner, P. Magill, and B. Lewis. 1980. Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur. J. Clin. Invest. 10: 161-172.
41. Goldstein, J. L., H. G. Schrott, W. R. Hazzard, E. L. Bierman, and A. G. Motulsky. 1973. Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest. 52: 1544-1568.
42. Aouizerat, B. E., H. Allayee, J. Bodnar, K. L. Krass, L. Peltonen, T. W. A. de Bruin, J. I. Rotter, and A. J. Lusis. 1999. Novel genes for familial combined hyperlipidemia. Curr. Opin. Lipidol. 10: 113-122.
43. Rauh, G., H. Schuster, B. Mueller, S. Schewe, C. Keller, G. Wolfram, and N. Zoellner. 1990. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia. Atherosclerosis. 83: 81-87.
44. Kwiterovich, P. O., Jr., S. White, T. Forte, P. S. Bachorik, S. Smith, and A. Sniderman. 1987. Hyperapolipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Arteriosclerosis. 7: 211-225.
45. Cullen, P., B. Farren, J. Scott, and M. Farrall. 1994. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler. Thromb. 14: 1233-1249.
46. Jarvik, G. P., J. D. Brunzell, M. A. Austin, R. M. Krauss, A. G. Motulsky, and E. Wijsman. 1994. Genetic predictors of FCHL in four large pedigrees. Influence of apoB level major locus predicted genotype and LDL subclass phenotype. Arterioscler. Thromb. 14: 1687-1694.
47. Bredie, S. J. H., J. van Drongelen, L. A. Kiemeney, P. N. Demacker, T. H. Beaty, and A. F. Stalenhoef. 1997. Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 17: 834-840.
48. Pajukanta, P., I. Nuotio, J. D. Terwilliger, K. V. Porkka, K. Ylitalo, J. Pihlajamaki, A. J. Suomalainen, A. C. Syvanen, T. Lehtimaki, J. S. A. Viikari, M. Laakso, M. R. Taskinen, C. Ehnholm, and L. Peltonen. 1998. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nature Genet. 18: 369-373.
49. Castellani, L. W., A. Weinreb, J. Bodnar, A. M. Goto, M. Doolittle, M. Mehrabian, P. Demant, and A. J. Lusis. 1998. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nature Genet. 18: 374-377.